Meso-azacyclic aromatic acid amides and esters as novel...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 487/04 (2006.01) C07D 471/08 (2006.01) C07D 471/18 (2006.01) C07D 487/08 (2006.01) C07D 519/00 (2006.01)

Patent

CA 2082415

ABSTRACT OF THE DISCLOSURE The meso-azacyclic aromatic acid amides and esters of the present invention are useful in the treatment of the central nervous system and gastrointestinal motility disorders such as gastroesophagaal reflux, non ulcer dyspepsia, delayed gastric emptying, ileus, irritable bowel syndrome, and the like. Additionally, the compounds of the present invention find utility as antagonists of serotonin 5-HT3 receptors. As such they are useful for the treatment of humans and animals wherein antagonism of 5-HT3 receptors is beneficial. Therapy is indicated for, but not limited to, the treatment of anxiety, psychoses, depression (especially depression accompanied by anxiety), cognitive disorders, substance abuse dependence and/or withdrawal, irritable bowel syndrome, emesis caused by chemotherapeutic agents, and visceral pain. Additionally, the compounds of the present invention may find utility as enhancers of nasal absorption of bioactive compounds.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Meso-azacyclic aromatic acid amides and esters as novel... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Meso-azacyclic aromatic acid amides and esters as novel..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Meso-azacyclic aromatic acid amides and esters as novel... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1693891

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.